← All Pediatrix Medical Group, INC filings

Pediatrix Medical Group, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
MD
Pediatrix Medical Group, INC
DEF: Pediatrix Sets 2026 Annual Meeting Agenda, Seeks Plan Approval
Pediatrix Medical Group, Inc. announced its 2026 Annual Shareholders Meeting to vote on director elections, auditor ratification, executive compensation, and a key incentive compensation plan amendment.
NYSE
MD
Pediatrix Medical Group, INC
DEFA14A: Pediatrix Medical Group Sets Date for Annual Shareholder Meeting, Outlines Key Proposals
Pediatrix Medical Group will hold its annual shareholder meeting on May 8, 2025, featuring proposals for director elections, auditor ratification, and executive compensation advisory vote.
NYSE
MD
Pediatrix Medical Group, INC
DEF: Pediatrix Medical Group Sets Date for 2025 Annual Shareholders Meeting, Outlines Key Proposals
Pediatrix Medical Group will hold its 2025 Annual Shareholders Meeting virtually on May 8, 2025, to vote on director elections, auditor ratification, executive compensation, and other business.
NYSE
MD
Pediatrix Medical Group, INC
DEFA14A: Pediatrix Medical Group Sets Date for Annual Shareholder Meeting, Outlines Key Proposals
Pediatrix Medical Group will hold its annual shareholder meeting on May 9, 2024, featuring proposals to elect directors, ratify the appointment of PricewaterhouseCoopers LLP, and conduct an advisory vote on executive compensation.
NYSE
MD
Pediatrix Medical Group, INC
DEF 14A: Pediatrix Medical Group Announces 2024 Annual Shareholders Meeting and Proxy Statement
Pediatrix Medical Group has released its proxy statement for the 2024 Annual Shareholders Meeting, detailing proposals for director elections, auditor ratification, and executive compensation.